Edaravone suspension for oral administration | Patent Publication Number 20210212990
US 20210212990 A1Patent NumberUS 11241416 B2
Application Number17213501
Filled DateMar 26, 2021
Priority DateNov 1, 2019
Publication DateJul 15, 2021
Original AssigneeMitsubishi Chemical Group Corporation
Current AssigneeMitsubishi Chemical Group Corporation
Inventor/ApplicantsTetsuo Hayama
Tetsuo HAYAMA
Tadashi MIYAZAWA
Tomohiro Takahashi
Tomoyuki OMURA
Kouji Hayashi
Tadashi Miyazawa
Tomohiro TAKAHASHI
Munetomo MATSUDA
Munetomo Matsuda
Tomoyuki Omura
Kouji HAYASHI
Tetsuo HAYAMA
Tadashi MIYAZAWA
Tomohiro Takahashi
Tomoyuki OMURA
Kouji Hayashi
Tadashi Miyazawa
Tomohiro TAKAHASHI
Munetomo MATSUDA
Munetomo Matsuda
Tomoyuki Omura
Kouji HAYASHI
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.